Abstract #0276

Hyperpolarized 13C Metabolic Imaging of Human Hypertrophic Cardiomyopathy

Angus Z. Lau^1,2, Albert P. Chen³, Justin Y.C. Lau^1,2, Benjamin J. Geraghty^1,2, William J. Perks⁴, Idan Roifman⁵, Graham A. Wright^1,2,5, Kim A. Connelly⁶, and Charles H. Cunningham^1,2

¹Physical Sciences Platform, Sunnybrook Research Institute, Toronto, ON, Canada, ²Medical Biophysics, University of Toronto, Toronto, ON, Canada, ³GE Healthcare, Toronto, ON, Canada, ⁴Pharmacy, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, ⁵Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, ⁶Cardiology, St. Michael's Hospital, Toronto, ON, Canada

The feasibility of using hyperpolarized ¹³C to interrogate in vivo human metabolism in the healthy heart has recently been demonstrated. In this abstract we demonstrate the feasibility of using hyperpolarized ¹³C imaging to detect metabolic alterations in human hypertrophic cardiomyopathy. Results show significantly elevated¹³C-bicarbonate-to-pyruvate ratio near the apex of the heart, corresponding to the known location of disease. The ¹³C-bicarbonate images also show a different spatial distribution from those observed in healthy volunteers. These results show good prospects for imaging the altered cardiac energetics in the diseased heart using this technology.

This abstract and the presentation materials are available to members only; a login is required.

Join Here